The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Open accessAbstract
Intrahepatic cholangiocarcinoma (iCCA) emerges inside the liver from bile ductules to the second-order bile ducts, represents the second most frequent primary liver cancer besides hepatocellular carcinoma and, unfortunately, is globally increasing in term of incidence. The silent presentation, late diagnosis, the highly aggressive nature and resistance to treatments lead to alarming mortality. Early diagnosis, molecular characterization, accurate staging and personalized multidisciplinary treatments represent challenges for researchers and physicians. Unfortunately, these challenges are beset by the high heterogeneity of iCCA at the clinical, genomic, epigenetic and molecular levels that very often preclude successful management. Nonetheless, in the last few years, progress has been achieved in molecular characterization, surgical management and targeted therapies. The recent advance together with the awareness that iCCA represents a distinct entity amongst the CCA family, led the ILCA and EASL governing boards to commission and charge international experts to draft dedicated guidelines to aid physicians towards an evidence-based approach for the diagnostic, prognostic, and therapeutic management of iCCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Self-citationCholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationAbou-Alfa, G. K., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A. S., Borad, M. J., Gallinson, D., Murphy, A. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30109-1 · Cited by 1,611
The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008
Buell, J. F., Cherqui, D., Geller, D. A., O’Rourke, N., Iannitti, D., Dagher, I., Koffron, A. J., Thomas, M., Gayet, B., Han, H. S., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b3b2d8 · Cited by 1,526
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Self-citationGenomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Primrose, J. N., Fox, R. P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., Falk, S., Finch-Jones, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30915-x · Cited by 1,273
Self-citationDiagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Self-citationDurvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
Oh, D.-Y., Ruth He, A., Qin, S., Chen, L.-T., Okusaka, T., Vogel, A., Kim, J. W., Suksombooncharoen, T., Ah Lee, M., Kitano, M., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200015 · Cited by 1,217
Self-citationMosele, F., Remon, J., Mateo, J., Westphalen, C. B., Barlesi, F., Lolkema, M. P., Normanno, N., Scarpa, A., Robson, M., Meric-Bernstam, F., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.014 · Cited by 1,186
Abou-Alfa, G. K., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V., Borad, M. J., Bridgewater, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30157-1 · Cited by 1,116
Self-citationHepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., Bachini, M., Borad, M., Brown, D., Burgoyne, A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0022 · Cited by 1,003
Self-citationRisk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
Mavros, M. N., Economopoulos, K. P., Alexiou, V. G., & Pawlik, T. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.5137 · Cited by 808
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
Glimelius, B., Hoffman, K., Sjödén, P.-O., Jacobsson, G., Sellström, H., Enander, L.-K., Linné, T., & Svensson, C. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010676 · Cited by 797
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Lamarca, A., Palmer, D. H., Wasan, H. S., Ross, P. J., Ma, Y. T., Arora, A., Falk, S., Gillmore, R., Wadsley, J., Patel, K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00027-9 · Cited by 769
Self-citationOkusaka, T., Nakachi, K., Fukutomi, A., Mizuno, N., Ohkawa, S., Funakoshi, A., Nagino, M., Kondo, S., Nagaoka, S., Funai, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605779 · Cited by 744
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, Takada, T., Amano, H., Yasuda, H., Nimura, Y., Matsushiro, T., Kato, H., Nagakawa, T., & Nakayama, T. (2002) · Cancer · doi:10.1002/cncr.10831 · Cited by 631
Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma
Goyal, L., Meric-Bernstam, F., Hollebecque, A., Valle, J. W., Morizane, C., Karasic, T. B., Abrams, T. A., Furuse, J., Kelley, R. K., Cassier, P. A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206834 · Cited by 613
Self-citationLowery, M. A., Ptashkin, R., Jordan, E., Berger, M. F., Zehir, A., Capanu, M., Kemeny, N. E., O'Reilly, E. M., El-Dika, I., Jarnagin, W. R., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0078 · Cited by 582
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D., & Khan, S. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.007 · Cited by 550
Edeline, J., Benabdelghani, M., Bertaut, A., Watelet, J., Hammel, P., Joly, J.-P., Boudjema, K., Fartoux, L., Bouhier-Leporrier, K., Jouve, J.-L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00050 · Cited by 541
Zhu, A. X., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., Borad, M. J., Bridgewater, J. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3836 · Cited by 509
Self-citationPrimary Sclerosing Cholangitis
Lazaridis, K. N., & LaRusso, N. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1506330 · Cited by 505
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Meyer, C. G., Penn, I., & James, L. (2000) · Transplantation · doi:10.1097/00007890-200004270-00019 · Cited by 502
HER2 expression status in diverse cancers: review of results from 37,992 patients
Yan, M., Schwaederle, M., Arguello, D., Millis, S. Z., Gatalica, Z., & Kurzrock, R. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9552-6 · Cited by 483
Maio, M., Ascierto, P. A., Manzyuk, L., Motola-Kuba, D., Penel, N., Cassier, P. A., Bariani, G. M., De Jesus Acosta, A., Doi, T., Longo, F., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.519 · Cited by 472
Hong, T. S., Wo, J. Y., Yeap, B. Y., Ben-Josef, E., McDonnell, E. I., Blaszkowsky, L. S., Kwak, E. L., Allen, J. N., Clark, J. W., Goyal, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.2710 · Cited by 472
Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0270 · Cited by 468
Ross, J. S., Wang, K., Gay, L., Al-Rohil, R., Rand, J. V., Jones, D. M., Lee, H. J., Sheehan, C. E., Otto, G. A., Palmer, G., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0352 · Cited by 454
Javle, M., Roychowdhury, S., Kelley, R. K., Sadeghi, S., Macarulla, T., Weiss, K. H., Waldschmidt, D.-T., Goyal, L., Borbath, I., El-Khoueiry, A., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00196-5 · Cited by 428
Self-citationWang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399
Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22441 · Cited by 393
Valle, J. W., Furuse, J., Jitlal, M., Beare, S., Mizuno, N., Wasan, H., Bridgewater, J., & Okusaka, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt540 · Cited by 391
Self-citationSapisochin, G., Facciuto, M., Rubbia‐Brandt, L., Marti, J., Mehta, N., Yao, F. Y., Vibert, E., Cherqui, D., Grant, D. R., Hernandez‐Alejandro, R., et al. (2016) · Hepatology · doi:10.1002/hep.28744 · Cited by 370
Self-citationMazzaferro, V., El-Rayes, B. F., Droz dit Busset, M., Cotsoglou, C., Harris, W. P., Damjanov, N., Masi, G., Rimassa, L., Personeni, N., Braiteh, F., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0334-0 · Cited by 365
Liver resection and transplantation for intrahepatic cholangiocarcinoma
Mazzaferro, V., Gorgen, A., Roayaie, S., Droz dit Busset, M., & Sapisochin, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.020 · Cited by 355
Self-citationSurgery for cholangiocarcinoma
Cillo, U., Fondevila, C., Donadon, M., Gringeri, E., Mocchegiani, F., Schlitt, H. J., Ijzermans, J. N. M., Vivarelli, M., Zieniewicz, K., Olde Damink, S. W. M., et al. (2019) · Liver International · doi:10.1111/liv.14089 · Cited by 335
Komuta, M., Govaere, O., Vandecaveye, V., Akiba, J., Van Steenbergen, W., Verslype, C., Laleman, W., Pirenne, J., Aerts, R., Yano, H., et al. (2012) · Hepatology · doi:10.1002/hep.25595 · Cited by 333
Self-citationMorizane, C., Okusaka, T., Mizusawa, J., Katayama, H., Ueno, M., Ikeda, M., Ozaka, M., Okano, N., Sugimori, K., Fukutomi, A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz402 · Cited by 322
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
Graham, R. P., Barr Fritcher, E. G., Pestova, E., Schulz, J., Sitailo, L. A., Vasmatzis, G., Murphy, S. J., McWilliams, R. R., Hart, S. N., Halling, K. C., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.03.014 · Cited by 313
Self-citationCholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 311
Oh, D.-Y., Lee, K.-H., Lee, D.-W., Yoon, J., Kim, T.-Y., Bang, J.-H., Nam, A.-R., Oh, K.-S., Kim, J.-M., Lee, Y., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00043-7 · Cited by 311
Tao, R., Krishnan, S., Bhosale, P. R., Javle, M. M., Aloia, T. A., Shroff, R. T., Kaseb, A. O., Bishop, A. J., Swanick, C. W., Koay, E. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3778 · Cited by 309
Edeline, J., Touchefeu, Y., Guiu, B., Farge, O., Tougeron, D., Baumgaertner, I., Ayav, A., Campillo-Gimenez, B., Beuzit, L., Pracht, M., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3702 · Cited by 306
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Self-citationLunsford, K. E., Javle, M., Heyne, K., Shroff, R. T., Abdel-Wahab, R., Gupta, N., Mobley, C. M., Saharia, A., Victor, D. W., Nguyen, D. T., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30045-1 · Cited by 298
Lau, S. K., Prakash, S., Geller, S. A., & Alsabeh, R. (2002) · Human Pathology · doi:10.1053/hupa.2002.130104 · Cited by 288
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Silverman, I. M., Hollebecque, A., Friboulet, L., Owens, S., Newton, R. C., Zhen, H., Féliz, L., Zecchetto, C., Melisi, D., & Burn, T. C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0766 · Cited by 283
Valle, J. W., Wasan, H., Lopes, A., Backen, A. C., Palmer, D. H., Morris, K., Duggan, M., Cunningham, D., Anthoney, D. A., Corrie, P., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00139-4 · Cited by 273
Self-citationLiau, J.-Y., Tsai, J.-H., Yuan, R.-H., Chang, C.-N., Lee, H.-J., & Jeng, Y.-M. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.241 · Cited by 265
Nakachi, K., Ikeda, M., Konishi, M., Nomura, S., Katayama, H., Kataoka, T., Todaka, A., Yanagimoto, H., Morinaga, S., Kobayashi, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02038-4 · Cited by 258
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
Le Roy, B., Gelli, M., Pittau, G., Allard, M. A., Pereira, B., Serji, B., Vibert, E., Castaing, D., Adam, R., Cherqui, D., et al. (2018) · Journal of British Surgery · doi:10.1002/bjs.10641 · Cited by 256
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Self-citationCercek, A., Boerner, T., Tan, B. R., Chou, J. F., Gönen, M., Boucher, T. M., Hauser, H. F., Do, R. K. G., Lowery, M. A., Harding, J. J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3718 · Cited by 228
Yoo, C., Kim, K.-P., Jeong, J. H., Kim, I., Kang, M. J., Cheon, J., Kang, B. W., Ryu, H., Lee, J. S., Kim, K. W., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00486-1 · Cited by 218
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
Bridgewater, J., Fletcher, P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., Falk, S., Finch-Jones, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02568 · Cited by 216
Self-citationSapisochin, G., Rodríguez de Lope, C., Gastaca, M., Ortiz de Urbina, J., Suarez, M. A., Santoyo, J., Castroagudín, J. F., Varo, E., López-Andujar, R., Palacios, F., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12591 · Cited by 197
Self-citationKato, A., Shimizu, H., Ohtsuka, M., Yoshidome, H., Yoshitomi, H., Furukawa, K., Takeuchi, D., Takayashiki, T., Kimura, F., & Miyazaki, M. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2312-8 · Cited by 176
Hayashi, A., Misumi, K., Shibahara, J., Arita, J., Sakamoto, Y., Hasegawa, K., Kokudo, N., & Fukayama, M. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000670 · Cited by 170
Cheon, Y. K., Cho, Y. D., Moon, J. H., Lee, J. S., & Shim, C. S. (2009) · Surgery · doi:10.1016/j.surg.2009.04.009 · Cited by 160
Toward integrated opisthorchiasis control in northeast Thailand: The Lawa project
Sripa, B., Tangkawattana, S., Laha, T., Kaewkes, S., Mallory, F. F., Smith, J. F., & Wilcox, B. A. (2014) · Acta Tropica · doi:10.1016/j.actatropica.2014.07.017 · Cited by 154
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review
Kim, H. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i48.13418 · Cited by 152
Lamarca, Á., Barriuso, J., Chander, A., McNamara, M. G., Hubner, R. A., O'Reilly, D. A., Manoharan, P., & Valle, J. W. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.038 · Cited by 152
Self-citationGlantzounis, G. K., Tokidis, E., Basourakos, S. P., Ntzani, E., Lianos, G. D., & Pentheroudakis, G. E. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.05.026 · Cited by 141
Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis
Ali, A. H., Tabibian, J. H., Nasser‐Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J., & Lindor, K. D. (2018) · Hepatology · doi:10.1002/hep.29730 · Cited by 140
Practical considerations in screening for genetic alterations in cholangiocarcinoma
Bekaii‐Saab, T., Bridgewater, J. A., & Normanno, N. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.04.012 · Cited by 139
Akita, M., Fujikura, K., Ajiki, T., Fukumoto, T., Otani, K., Azuma, T., Itoh, T., Ku, Y., & Zen, Y. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.22 · Cited by 138
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
Iavarone, M. A., Piscaglia, F., Vavassori, S., Galassi, M., Sangiovanni, A., Venerandi, L., Forzenigo, L. V., Golfieri, R., Bolondi, L., & Colombo, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.013 · Cited by 124
Campbell, W. L., Ferris, J. V., Holbert, B. L., Thaete, F. L., & BARON, R. L. (1998) · Radiology · doi:10.1148/radiology.207.1.9530297 · Cited by 123
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
Chong, D. Q., & Zhu, A. X. (2016) · Oncotarget · doi:10.18632/oncotarget.8775 · Cited by 122
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review
Rizzo, A., & Brandi, G. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100354 · Cited by 121
Galassi, M., Iavarone, M. A., Rossi, S. M., Bota, S. I., Vavassori, S., de la Rosa, L. E. S., Leoni, S., Venerandi, L., Marinelli, S., Sangiovanni, A., et al. (2013) · Liver International · doi:10.1111/liv.12124 · Cited by 117
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
Yadav, S., Xie, H., Riaz, I. B., Sharma, P., Durani, U., Goyal, G., Borah, B. J., Borad, M. J., Smoot, R. L., Roberts, L. R., et al. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.03.023 · Cited by 113
Fujita, N., Asayama, Y., Nishie, A., Ishigami, K., Ushijima, Y., Takayama, Y., Okamoto, D., Moirta, K., Shirabe, K., Aishima, S., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4386-3 · Cited by 110
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhang, Z., Huang, Q., Yu, L., Zhu, D., Li, Y., Xue, Z., Hua, Z., Luo, X., Song, Z., Lu, C. C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.807895 · Cited by 108
Kozaka, K., Sasaki, M., Fujii, T., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02735.x · Cited by 102
Ma, B., Meng, H., Tian, Y., Wang, Y., Song, T., Zhang, T., Wu, Q., Cui, Y., Li, H., Zhang, W., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06804-6 · Cited by 99
Yoon, J. G., Kim, M. H., Jang, M., Kim, H., Hwang, H. K., Kang, C. M., Lee, W. J., Kang, B., Lee, C., Lee, M. G., et al. (2021) · Hepatology · doi:10.1002/hep.31862 · Cited by 97
Prytz, H., Keiding, S., Björnsson, E. S., Broomé, U., Almer, S. H., Castedal, M., & Munk, O. L. (2006) · Hepatology · doi:10.1002/hep.21433 · Cited by 90
Outcomes of Hepatectomy for Hepatolithiasis
Lee, T., Chen, Y., Chang, H., Chan, C., & Kuo, S. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0441-6 · Cited by 89
Si, A., Li, J., Yang, Z., Xia, Y., Yang, T., Lei, Z., Cheng, Z., Pawlik, T. M., Lau, W. Y., & Shen, F. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07260-8 · Cited by 88
Li, J., Moustafa, M., Linecker, M., Lurje, G., Capobianco, I., Baumgart, J., Ratti, F., Rauchfuß, F., Balcı, D., Fernandes, E. S. M., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08192-z · Cited by 85
Ahn, K. S., O’Brien, D. R., Kang, Y. N., Mounajjed, T., Kim, Y., Kim, T., Kocher, J., Allotey, L. K., Borad, M. J., Roberts, L. R., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09954-3 · Cited by 83
Sripa, B., Tangkawattana, S., & Sangnikul, T. (2016) · Parasitology International · doi:10.1016/j.parint.2016.11.013 · Cited by 81
Reames, B. N., Ejaz, A. M., Koerkamp, B. G., Alexandrescu, S. T., Marques, H. P., Aldrighetti, L. A., Maithel, S. K., Pulitanò, C., Bauer, T. W., Shen, F., et al. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24633 · Cited by 81
Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
Chijiiwa, K., Ichimiya, H., Kuroki, S., et al. (1993) · PubMed · Cited by 80
Fong, Z. V., Brownlee, S. A., Qadan, M., & Tanabe, K. K. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-09671-y · Cited by 80
Cho, J. Y., Han, H., Wakabayashi, G., Soubrane, O., Geller, D. A., O’Rourke, N., Buell, J. F., & Cherqui, D. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2017.12.003 · Cited by 79
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
Lamarca, Á., Santos‐Laso, Á., Utpatel, K., Casta, A. L., Stock, S., Forner, A., Adeva, J., Folseraas, T., Fabris, L., Macías, R. I. R., et al. (2020) · Hepatology · doi:10.1002/hep.31598 · Cited by 79
Self-citation[F-18]Fluorodeoxyglucose Positron Emission Tomography and Positron Emission Tomography
Jadvar, H., Henderson, R. W., & Conti, P. S. (2007) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000237811.88251.d7 · Cited by 76
Mason, M. C., Massarweh, N. N., Tzeng, C.-W. D., Chiang, Y., Chun, Y. S., Aloia, T. A., Javle, M. M., Vauthey, J., & Cao, H. S. T. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09536-w · Cited by 74
Serenari, M., Zanello, M., Schadde, E., Toschi, E., Ratti, F., Gringeri, E., Masetti, M., Cillo, U., Aldrighetti, L. A., Jovine, E., et al. (2016) · HPB · doi:10.1016/j.hpb.2016.02.003 · Cited by 73
Goeppert, B. F., Folseraas, T., Roessler, S. K., Kloor, M., Volckmar, A., Endris, V., Buchhalter, I., Stenzinger, A., Grzyb, K., Grimsrud, M. M., et al. (2020) · Hepatology · doi:10.1002/hep.31110 · Cited by 71
Valle, J. W., Vogel, A., Denlinger, C. S., He, A. R., Bai, L., Орлова, Р. В., Cutsem, E. V., Adeva, J., Chen, L., Obermannova, R. L., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00409-5 · Cited by 70
Self-citationPathologic differential diagnosis of metastatic carcinoma in the liver
Park, J. H., & Kim, J. H. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0067 · Cited by 69
Self-citationUtuama, O. A., Permuth, J. B., Dagne, G. A., Sanchez-Anguiano, A., Alman, A. C., Kumar, A., Denbo, J. W., Kim, R. D., Fleming, J. B., & Anaya, D. A. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09478-3 · Cited by 65
Akita, M., Sofue, K., Fujikura, K., Otani, K., Itoh, T., Ajiki, T., Fukumoto, T., & Zen, Y. (2018) · HPB · doi:10.1016/j.hpb.2018.07.021 · Cited by 64
Xu, C., Li, L., Xu, W. L., Du, C., Yang, L., Tong, J., & Yi, Y. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1571247 · Cited by 61
Ziogas, I. A., Giannis, D., Economopoulos, K. P., Hayat, M. H., Montenovo, M. I., Matsuoka, L. K., & Alexopoulos, S. P. (2020) · Transplantation · doi:10.1097/tp.0000000000003539 · Cited by 61
Lee, H., & Ross, J. S. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17698090 · Cited by 60
Wang, H. L., Kim, C. J., Koo, J., Zhou, W., Choi, E. K., Arcega, R. S., Chen, Z. E., Wang, H., Zhang, L., & Lin, F. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0489-ra · Cited by 60
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment
Alvaro, D., Hassan, C., Cardinale, V., Carpino, G., Fabris, L., Gringeri, E., Granata, V., Mutignani, M., Morement, H., Giuliante, F., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.08.030 · Cited by 60
Self-citationCampbell, W. L., Peterson, M. S., Federle, M. P., Siqueira, E. S., Slivka, A., Grazioli, L., Ichikawa, T., Oliver, J. H., Kim, T., & Li, W. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.5.1771095 · Cited by 59
Zhang, K., Yu, J., Yu, X., Han, Z., Cheng, Z., Liu, F., & Liang, P. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1327678 · Cited by 57
Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma
Buettner, S., ten Cate, D. W. G., Bagante, F., Alexandrescu, S. T., Marques, H. P., Lamelas, J., Aldrighetti, L. A., Gamblin, T. C., Maithel, S. K., Pulitanò, C., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04184-2 · Cited by 57
Watanabe, Y., Matsuyama, Y., Izumi, N., et al. (2020) · Surgery · doi:10.1016/j.surg.2019.12.009 · Cited by 56
Kusano, T., Isa, T., Ohtsubo, M., Yasaka, T., & Furukawa, M. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200108000-00004 · Cited by 53
Ito, T., Butler, J. R., Noguchi, D., Ha, M., Aziz, A., Agopian, V. G., DiNorcia, J., Yersiz, H., Farmer, D. G., Busuttil, R. W., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26285 · Cited by 53
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
Bergquist, A. M., Weismüller, T. J., Levy, C., Rupp, C., Joshi, D., Nayagam, J. S., Montaño‐Loza, A. J., Lytvyak, E., Wunsch, E., Milkiewicz, P., et al. (2022) · Liver International · doi:10.1111/liv.15286 · Cited by 53
Israel, M. A., Danziger, N. A., McGregor, K., Murugesan, K., Gjoerup, O. V., Sokol, E. S., Tukachinsky, H., Kurzrock, R., Kato, S., Sicklick, J. K., et al. (2021) · The Oncologist · doi:10.1002/onco.13844 · Cited by 51
Misumi, K., Hayashi, A., Shibahara, J., Arita, J., Sakamoto, Y., Hasegawa, K., Kokudo, N., & Fukayama, M. (2016) · Histopathology · doi:10.1111/his.13127 · Cited by 47
Padden, J., Ahrens, M., Kälsch, J., Bertram, S., Megger, D. A., Bracht, T., Eisenacher, M., Kocabayoglu, P., Meyer, H. E., Sipos, B., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054585 · Cited by 44
Cholangiocarcinoma Risk as Long‐term Outcome After Hepatic Resection in the Hepatolithiasis Patients
Kim, H. J., Kim, J. S., Suh, S. J., Lee, B. J., Park, J., Lee, H. S., Kim, C. D., & Bak, Y. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-2965-0 · Cited by 43
Self-citationMDM2 Amplification in Intrahepatic Cholangiocarcinomas
Kim, S. J., Akita, M., Sung, Y., Fujikura, K., Lee, J. H., Hwang, S., Yu, E., Otani, K., Hong, S., & Zen, Y. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001006 · Cited by 43
Huang, X., Yang, J., Li, J., & Xiong, Y. (2020) · Medicine · doi:10.1097/md.0000000000020932 · Cited by 42
Kim, Y., Yeom, S. K., Shin, H. J., Choi, S. H., Rhee, H., Park, J. H., Cho, E., Park, S., Lee, S. S., & Park, M. (2021) · Hepatology Communications · doi:10.1002/hep4.1774 · Cited by 41
Self-citationSutton, T. L., Billingsley, K. G., Walker, B. S., Enestvedt, C. K., Dewey, E. N., Orloff, S. L., & Mayo, S. C. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.02.029 · Cited by 40
Díaz‐González, Á., Vilana, R., Bianchi, L., García‐Criado, Á., Rimola, J., de Lope, C. R., Ferrer, J., Ayuso, C., da Fonseca, L. G., Reig, M., et al. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.06.014 · Cited by 39
Self-citationCholangiocarcinoma in patients with primary sclerosing cholangitis
Fung, B. M., & Tabibian, J. H. (2019) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000616 · Cited by 39
Fruscione, M., Pickens, R. C., Baker, E. H., Martinie, J. B., Iannitti, D. A., Hwang, J. J., & Vrochides, D. V. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2020.100614 · Cited by 38
Le, V. H., O’Connor, V. V., Li, D., Melstrom, L. G., Fong, Y., & DiFronzo, A. L. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26230 · Cited by 38
Sahara, K., Tsilimigras, D. I., Mehta, R., Bagante, F., Guglielmi, A., Aldrighetti, L. A., Alexandrescu, S. T., Marques, H. P., Shen, F., Koerkamp, B. G., et al. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25480 · Cited by 37
Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma
Si, A., Li, J., Xiang, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17815 · Cited by 35
Thinkhamrop, K., Khuntikeo, N., Sithithaworn, P., Thinkhamrop, W., Wangdi, K., Kelly, M., Suwannatrai, A. T., & Gray, D. J. (2019) · Infectious Diseases of Poverty · doi:10.1186/s40249-019-0529-5 · Cited by 34
Chung, T., Rhee, H., Shim, H. S., Yoo, J. E., Choi, G. H., Kim, H., & Park, Y. N. (2021) · Gut and Liver · doi:10.5009/gnl210174 · Cited by 32
Yin, L., Zhao, S., Zhu, H., Ji, G., & Zhang, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-91823-x · Cited by 31
Jesper, D., Heyn, S. G., Schellhaas, B., Pfeifer, L., Goertz, R. S., Zopf, S., Neurath, M. F., & Strobel, D. D. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001036 · Cited by 27
Early detection of intrahepatic cholangiocarcinoma
Hamaoka, M., Kozaka, K., Matsui, O., Komori, T., Matsubara, T., Yoneda, N., Yoshida, K., Inoue, D., Kitao, A., Koda, W., et al. (2019) · Japanese Journal of Radiology · doi:10.1007/s11604-019-00860-0 · Cited by 26
Laithavewat, L., Grundy‐Warr, C., Khuntikeo, N., Andrews, R. H., Petney, T. N., Yongvanit, P., Banchonhattakit, P., & Sithithaworn, P. (2018) · Global Health Promotion · doi:10.1177/1757975918767622 · Cited by 25
Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost‐Utility Analysis
Cillo, U., Spolverato, G., Vitale, A., Ejaz, A. M., Lonardi, S., Cosgrove, D. C., & Pawlik, T. M. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3150-1 · Cited by 23
Non-invasive diagnosis of hepatocellular carcinoma revisited
Mueller, C., Waldburger, N., Stampfl, U., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314981 · Cited by 21
Walker, S. L., & McCormick, P. A. (2007) · Abdominal Imaging · doi:10.1007/s00261-007-9314-1 · Cited by 20
Wang, T., Drill, E. N., Vakiani, E., Pak, L. M., Boerner, T., Aşkan, G., Schvartzman, J. M., Simpson, A. L., Jarnagin, W. R., & Sigel, C. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.05.002 · Cited by 20
Sebastian, N., Tan, Y., Miller, E. D., Williams, T. M., Noonan, A. M., Hays, J. L., Abdel‐Misih, S., & Diaz, D. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.11154 · Cited by 18
Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer
Nara, S., Esaki, M., Ban, D., Takamoto, T., Mizui, T., & Shimada, K. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1911645 · Cited by 15
Vinnitskaya, E. V., Abdulkhakov, S. R., Тинович, А. Д., Alikhanov, R., Бакулин, И. Г., Александровна, Б. Е., Bueverov, A. O., Burnevitch, E. Z., Efanov, M., Eremina, E. Y., et al. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.02.000075 · Cited by 13
Wang, T., Zhang, J., Wang, W., Yang, X., Kong, J., Shen, S. Y., & Wang, W. (2020) · Cancer Management and Research · doi:10.2147/cmar.s272797 · Cited by 12
Satiya, J., Mousa, O. Y. S., Gupta, K., Trivedi, S., Oman, S. P., Wijarnpreecha, K., Harnois, D. M., & Corral, J. E. (2020) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2020.93054 · Cited by 10
Bukkhunthod, P., Meererksom, T., Pechdee, P., Ponphimai, S., Khiaowichit, J., Kaewpitoon, N., Thueng-in, K., Leng, M., Namhong, T., Taweepakdeechot, A., et al. (2018) · Journal of Cancer Education · doi:10.1007/s13187-018-1434-5 · Cited by 9
Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?
Lang, H. (2021) · British journal of surgery · doi:10.1093/bjs/znab077 · Cited by 9
Owen, M., & Beal, E. W. (2021) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s319027 · Cited by 7
Wu, J., Ji-liang, F., Zhu, R., Liu, S.-G., Zhao, D., & Li, N. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i5.404 · Cited by 5
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter?
Vyas, M., & Deshpande, V. (2021) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2021.11.002 · Cited by 3
Metadata
- Authors
- Alvaro, D., Gores, G. J., Walicki, J., Hassan, C., Sapisochin, G., Komuta, M., Forner, A., Valle, J. W., Laghi, A., Ilyas, S. I., Park, J.-W., Kelley, R. K., Reig, M., & Sangro, B.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2023-07
- Volume
- 79
- Issue
- 1
- Pages
- 181-208
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4366490166
- Cited by
- 344
- References
- 152
- FWCI
- 81.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.